Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ · Healthcare
Lexicon Pharmaceuticals, Inc. Revenue 2009–2025
Lexicon Pharmaceuticals, Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Lexicon Pharmaceuticals, Inc. revenue for the quarter ending March 31, 2026 was 21.1 M, a 1572.11% increase year-over-year.
- Lexicon Pharmaceuticals, Inc. revenue for the twelve months ending March 31, 2026 was 65.4 M, a 1322.31% increase year-over-year.
- Lexicon Pharmaceuticals, Inc. annual revenue for 2025 was 49.8 M, a 729.91% increase from 2024.
- Lexicon Pharmaceuticals, Inc. annual revenue for 2024 was 6.0 M, a 440.63% increase from 2023.
- Lexicon Pharmaceuticals, Inc. annual revenue for 2023 was 1.1 M.
- Lexicon Pharmaceuticals, Inc. annual revenue for 2022 was 0.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Lexicon Pharmaceuticals, Inc. Market Cap — FAQ
Lexicon Pharmaceuticals, Inc. (LXRX) market cap over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LXRX's market cap history?
The chart and table above show Lexicon Pharmaceuticals, Inc.'s market cap by year and by quarter, including the growth rate.